Sildenafil 25 mg ODT + Collagenase Clostridium histolyticum vs Collagenase Clostridium histolyticum Alone for the Management of Peyronie’s Disease: A Matched-Pair Comparison Analysis Andrea Cocci MD, PhD; Gianmartin Cito MD; Daniele Urzì MD; Andrea Minervini MD; Fabrizio Di Maida MD; Francesco Sessa MD; Andrea Mari MD; Riccardo Campi MD; Marco Falcone MD; Marco Capece MD; […]
Penile Sensory Changes After Plaque Incision and Grafting Surgery for Peyronie’s Disease Jean E. Terrier, MD; Raanan Tal, MD, FECSM; Christian J. Nelson, PhD; John P. Mulhall, MD, MSC, FECSM, FACS FIRST PUBLISHED: September 5, 2018 – The Journal of Sexual Medicine DOI: https://doi.org/10.1016/j.jsxm.2018.07.020 Introduction Surgical procedures are considered the gold standard […]
While there are published guidelines for the treatment of Peyronie’s disease (PD), there is no consensus among surgeons on the best strategies.
This study examined surgeons’ practice patterns for pre-, intra-, and postoperative PD care in different continents and among members of sexual medicine societies.
This study examined the functional and subjective outcomes in patients who had concomitant length and girth restoration with the multiple-slit technique (MUST.)
This study compared the outcomes and satisfaction rates for two types of implant in patients with Peyronie’s Disease and ED.
This prospective, randomized, open-label pilot study explored the effects of vacuum-pump therapy, with and without penile modeling, in men receiving Collagenase Clostridium histolyticum (CCH). The authors noted that penile modeling and vacuum therapy “share underlying physiologic mechanisms.”